Inkef Capital
Edit

Inkef Capital

https://www.inkefcapital.com
Last activity: 17.03.2022
INKEF Capital is an early stage venture capital firm based in Amsterdam. From the very early stages of a technology or lifescience venture, INKEF Capital supports entrepreneurs building their ideas into successful international businesses. INKEF Capital covers multiple investment stages but focuses mainly on series A investments. For exceptional teams it also considers seed capital to turn a great idea into a company or growth capital to give a running start-up the next push. INKEF Capital is the partner for the long haul. Focus areas: Technology and Healthcare
Mentions
34
Location: Netherlands, North Holland, Amsterdam
Employees: 11-50
Phone:1389902
Founded date: 2010
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Mentions in press and media 34

DateTitleDescriptionSource
17.03.2022Precirix raises EUR 80m in Series B to advance its pipeline ...Brussels, Belgium, 16 March 2022 – Precirix NV, a clinical-stage biotechnology company developing pr...healthcap....
15.03.2022Providing “Amazon-level” reach and instant access to over 20...Dutch online marketplace integration platform ChannelEngine has raised $50 million in a Series B fun...tech.eu/20...
20.09.2021Clinical progression and €8M funding for Calypso BiotechCalypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and ...startuptic...
26.08.2021Cardior Raises €64 M Series B to Advance Clinical Pipeline o...Oversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inh...hadeanvent...
02.06.2021Amsterdam’s financial transaction monitoring system Sentinel...Amsterdam-based financial transaction monitoring system Sentinels has raised £4.9 million in a seed ...tech.eu/br...
23.04.2021Fresh capital for ONWARD to tackle spinal code injuriesONWARD’s ARC therapy can be delivered by an implantable system called ARC-IM and an external system ...startuptic...
23.04.2021Fresh capital for ONWARD to tackle spinal cord injuries ONWARD’s ARC therapy can be delivered by an implantable system called ARC-IM and an external syste...startuptic...
19.01.2021Amsterdam-based INKEF Capital leads €5M Series A funding rou...Of late, the marketplace model has been gaining a lot of momentum, encouraging many small to medium ...siliconcan...
14.07.2020iOnctura extends series A round to €20 millioniOnctura SA is a clinical-stage biopharmaceutical company developing a pipeline of next-generation m...startuptic...
14.07.20203B Future Health Fund Announces New Investment in iOncturaMONACO, PRINCIPALITY OF MONACO, 14 July 2020: 3B Future Health Fund, previously known as Helsinn Inv...3bfuturehe...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In